Clinical Trials on Adenocarcinoma, nyálkás

Total 9445 results

China Medical University, China

Not yet recruiting

Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance

Gastric Adenocarcinoma
Fondazione Poliambulanza Istituto Ospedaliero
Associazione Italiana per la Ricerca sul Cancro

Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. (ADAPTA)

Ampullary Adenocarcinoma

Italy
Cancer Trials Ireland

Recruiting

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Pancreatic Adenocarcinoma

Ireland
Tongji Hospital
Shanxi Province Cancer Hospital; Chongqing University Cancer Hospital; Fudan... and other collaborators

Not yet recruiting

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas (NPPC)

Periampullary Adenocarcinoma

China
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Treatment Response in Patients With PAC. (CANOPE)

Pancreatic Adenocarcinoma

France
Medical College of Wisconsin
Barbara Ann Karmanos Cancer Institute; Cornerstone Pharmaceuticals

Recruiting

CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma

United States
Sohag University

Recruiting

Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

Pancreatic Adenocarcinoma

Egypt
Medical College of Wisconsin

Recruiting

Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma (TRACT DNA)

Adenocarcinoma Esophagus

United States
Capital Health System, Inc

Recruiting

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
Illuminare Biotechnologies

Recruiting

Fluorescent Imaging of Nerves With Illuminare-1 During Surgery

Prostate Adenocarcinoma

United States
Medical College of Wisconsin

Recruiting

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Rectal Adenocarcinoma

United States
Federation Francophone de Cancerologie Digestive

Recruiting

Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma (AMPULLOMA)

Ampullary Adenocarcinoma

France
Tata Memorial Centre
Tata Medical Center

Recruiting

Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) (PRIME)

Prostate Adenocarcinoma

India
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Organon Healthcare GmbH

Active, not recruiting

Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany
Ohio State University Comprehensive Cancer Center

Completed

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Pancreatic Adenocarcinoma

United States
The Guthrie Clinic

Terminated

Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus (SAGE)

Adenocarcinoma Esophagus

United States
Stanford University

Completed

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

Pancreatic Adenocarcinoma

United States
NovoCure Ltd.

Active, not recruiting

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Pancreas Adenocarcinoma

United States, China, Belgium, Czechia, Korea, Republic of, Spain, Hong Kong, France, Australia, Italy, Hungary, Germany, Croatia, Canada, Mexico, Israel, Austria, Switzerland, Brazil, Poland
Institut für Klinische Krebsforschung IKF GmbH...

Active, not recruiting

Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany
Centre Leon Berard

Active, not recruiting

The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) (BIGHPANC)

Pancreas Adenocarcinoma

France
University of Texas Southwestern Medical Center

Completed

Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Mayo Clinic

Withdrawn

Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids

Pancreas Adenocarcinoma
China Resources Sanjiu Medical & Pharmaceutical...

Active, not recruiting

A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu

Gastric Adenocarcinoma

China
NorthShore University HealthSystem
University of Chicago

Completed

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Carol Davila University of Medicine and Pharmacy
Institutul Clinic Fundeni; Bucharest Emergency Hospital

Unknown

The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma (EUS-FNA)

Pancreatic Adenocarcinoma

Romania
University of Utah
Bristol-Myers Squibb; Acrotech Biopharma Inc.

Withdrawn

Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation (BENEFIT)

Metastatic Adenocarcinoma
Shanghai Jiao Tong University School of Medicine
Shanghai Zhongshan Hospital; Ruijin Hospital

Unknown

A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma.

Pancreas Adenocarcinoma

China
Memorial Sloan Kettering Cancer Center
Adera Labs, LLC

Completed

Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Fujian Cancer Hospital

Unknown

Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
The University of Texas Health Science Center,...

Withdrawn

Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma
Peking University

Active, not recruiting

Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. (RESOLVE-2)

Gastric Adenocarcinoma

China
Fujian Cancer Hospital

Unknown

Phase I Study of the Combination of Apatinib and POF

Gastric Adenocarcinoma

China
NovoCure Ltd.

Unknown

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Pancreatic Adenocarcinoma

Spain, Switzerland
Medical University of South Carolina

Terminated

Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas

Adenocarcinoma Pancreas

United States
Shanghai Zhongshan Hospital
Fudan University; RenJi Hospital; Ruijin Hospital; Xinhua Hospital, Shanghai Jiao...

Unknown

Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma (Neo-Classic)

Gastric Adenocarcinoma

China
Société Française d'Endoscopie Digestive

Completed

Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

France
AmpliMed Corporation

Completed

Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

Russian Federation
Emory University
Novartis

Terminated

Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma

Gastric Adenocarcinoma

United States
Thomas Jefferson University
Context Therapeutics Inc.

Active, not recruiting

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Refractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Rectal Cancer | Rectal Adenocarcinoma | Adenocarcinoma of the Rectum | Locally Advanced Rectal Adenocarcinoma | HER2 Positive Rectal Adenocarcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma

United States
University Hospital Schleswig-Holstein
University of Leipzig; University of Luebeck; University of Hamburg-Eppendorf; University... and other collaborators

Active, not recruiting

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus (ESOPEC)

Adenocarcinoma of the Esophagogastric Junction | Esophageal Adenocarcinoma (UICC TNM7)

Germany
Multitude Therapeutics Inc.
Tigermed Consulting Co., Ltd

Recruiting

AMT-151 in Patients With Selected Advanced Solid Tumours

Ovarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditions

China, Australia
National Cancer Institute (NCI)

Active, not recruiting

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditions

United States
Translational Oncology Research International
Sanofi; University of California, Los Angeles; OSI Pharmaceuticals

Completed

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Unresectable Adenocarcinoma of the Esophagus | Metastatic Adenocarcinoma of the Esophagus | Unresectable Adenocarcinoma of Gastric Cardia | Metastatic Adenocarcinoma of Gastric Cardia

United States
Henan University of Traditional Chinese Medicine

Recruiting

Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment

Early Stage Lung Adenocarcinoma

China
Fujian Medical University Union Hospital
Wu Jieping Medical Foundation

Active, not recruiting

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

IA Lung Adenocarcinoma | Combined Segmentectomy

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

Stage IV Lung Adenocarcinoma

United States
IRCCS San Raffaele

Completed

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

Stage I Pulmonary Adenocarcinoma

Italy

Clinical Trials on Adenocarcinoma, nyálkás

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations